TY027

· Tychan Pte Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TY027, covering 2022-03-24 to 2022-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans [Phase 3]